
PRVA Stock Forecast & Price Target
PRVA Analyst Ratings
Bulls say
Privia Health Group Inc has successfully executed Care Partners deals, achieving a 20% year-over-year growth in MSSP beneficiaries, a notable increase in savings rates by 150 basis points, and the implementation of over 100 providers since their $25 million acquisition of CMG in February 2023. The company has demonstrated a strong ability to enter new markets while recognizing the importance of organic growth among providers in existing markets to meet long-term targets. As Privia scales through partnerships with large health systems and medical groups, it remains focused on expanding its networks by engaging individual physicians, which underscores its commitment to optimizing physician practices and enhancing patient care.
Bears say
Privia Health Group Inc. faces a challenging outlook as its operating partners are anticipating a notable decline in Medicaid enrollment, projected at 8%-10% on a same-store basis by year-end. This decline is attributed to re-determination activities following the conclusion of the public health emergency, which is expected to negatively impact revenue and operational stability. As Medicaid plays a vital role in the healthcare landscape, the expected decrease in membership could hinder Privia Health's growth prospects and overall financial performance.
This aggregate rating is based on analysts' research of Privia Health Group and is not a guaranteed prediction by Public.com or investment advice.
PRVA Analyst Forecast & Price Prediction
Start investing in PRVA
Order type
Buy in
Order amount
Est. shares
0 shares